FAST NEWS: SSY Group Signs Preliminary Deal to Make Fever Medication
The latest: SSY Group Ltd. (2005.HK) said on Sunday it signed a letter of intent with a well-known Chinese pharmaceutical company to produce 1 billion to 2.5 billion ibuprofen sustained-release…
RELATED ARTICLES
-
FAST NEWS: EUDA Health to merge with developer of cancer, women’s health treatments
EUDA.US
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK
-
WuXi Biologics hatches new baby with ADC drug unit IPO
2269.HK
-
FAST NEWS: GCL Technology signs major polysilicon supply deal
3800.HK
- InSilico seeks IPO boost to get AI drugs over the line
Discover hidden China stock gems in our weekly newsletter